Similarly, Eric Polley, PhD, a UChicago data science and public health expert, recently led a study published in Nature Cardiovascular Research that used statistical modeling to emulate a clinical trial comparing the effects of four different classes of diabetes medication in patients with moderate cardiovascular risk
Figure 14: Diagram showing the contrasting functions of glucagon and insulin, credit: Carogonz11, Wikimedia
But no matter what shes done, Hargens, 34, says shes struggled to lose that last stubborn 15 pounds until she came across a product marketed as GLP-1 patches, playing off the current popularity of medications like Ozempic
Anaesth Rep 2024;12:e12278.ArticlePubMedPMC 18
In addition, functional study demonstrated that local injection of GLP-1 into the BNST induces food suppression during the dark phase (Williams et al., 2018)
"With these positive data in hand, we are now planning to submit orforglipron for regulatory review by year-end and are prepared for a global launch to address this urgent public health need." According to Eli Lilly, adults in the Phase 3 trials all lost weight with orforglipron and on the highest dose of 36 mg of orforglipron, the trial participants lost about 27 pounds over the course of 72 weeks or about 12% of their body weight, which is meaningful but not quite as high as some injectables
